Skip to content
Monday, November 9, 2026
VividCraft UK

The Zimbabwean Government Rejects ‘Lopsided’ US Healthcare Assistance Package Due to Information Apprehensions

Health aid illustration
The proposed US funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a major American health deal valued at 367 million US dollars (272 million pounds) over five years because of the United States' insistence on confidential data.

The decision became public after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".

A government representative has since clarified that the United States was demanding access to health data for research and commercial gain while was unwilling to guarantee the resulting advantages from any future treatments.

"We must now begin the challenging and unfortunate task of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for continued negotiations to find a agreement suitable to all parties so the country's critical HIV treatment initiative can proceed.

Wider Implications

This development follows a similar situation in neighbouring Kenya, where a court suspended a related deal with the US after legal challenges were filed about the security of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.

As per reports, Sixteen nations in Africa have so far signed similar agreements, constituting more than $18.3bn of fresh investment.

Details of the Rejected Agreement

The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this cooperation would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.

"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our population if a new disease outbreak arise."

National Interest and Global Health

Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining systems already set up through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.

"This system is designed to ensure that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.

"We are open to continued discussions with our American counterparts on how subsequent collaboration might be designed in a way that honours the sovereignty and interests of both nations."

Health Experts Response

A leading public health body expressed it acknowledged the official position, but suggested that talks need to persist given that much of the country's Aids initiatives were funded by international support.

"If specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it said.

The halted deal emphasises the complex tensions between receiving vital foreign assistance and protecting local interests in an increasingly data-driven world.

BG
By

Brandy Greene

A passionate DIY enthusiast and home improvement expert with over a decade of experience in crafting and renovation projects.

VividCraft UK

Type to search articles.